[ China Pharmaceutical Network Technology News ] US drug manufacturers and the US Food and Drug Administration (FDA) can quickly track prescription drugs through interoperable blockchains to detect and combat counterfeit drugs on the market. It is reported that the solution was developed by Chronicled, a blockchain startup from San Francisco, in collaboration with LinkLab, a life sciences supply chain.
Recently, the two companies launched a one-day "track and trace" test in San Francisco. The solution is developed specifically for the pharmaceutical industry or will be a viable way to combat the sale of counterfeit drugs in the US and elsewhere. Participating in the blockchain test activities are not only representatives of pharmaceutical companies, wholesalers and hospitals around the world, but also enterprise-level IT giants and blockchain technology companies. The event marked the first phase of the development of the interoperable blockchain platform for the pharmaceutical industry.
Chronicled co-founder and CEO Samantha Radocchia said in the report:
“In the coming months, we will work closely with leading teams in enterprise blockchain projects to identify the enterprise blockchain that is best suited to provide data entities for the pharmaceutical industry.â€
The blockchain platform will comply with the FDA's Drug Supply Chain Security Act (DSCSA), which was signed by former US President Barack Obama in November 2013. The bill aims to "develop an electronic interoperability system to identify and track certain prescription drugs distributed across the country."
With this in mind, the blockchain solution will support and comply with the DSCSA protocol. In addition, the pilot solution will focus on data privacy while complying with the GS1 standard. GS1 is a global traceability standardization system implemented by all participants in cross-border supply chains around the world.
All in all, this blockchain technology solution aims to develop a cheaper, faster, more efficient and safer standardized method to promote the distribution of prescription drugs.
LinkLab co-founder Susanne Somerville said: "The first phase of the project is to demonstrate that a global pharmaceutical manufacturer can comply with DSCSA regulatory requirements and meet the needs of 2017-2023. In the first phase, we are very happy with a large pharmaceutical manufacturer. cooperating."
There will be other participants in the coming stage, joining all aspects of the typical pharmaceutical supply chain process from manufacturer to pharmacy, hospital, etc.
One of the core products of blockchain technology is a ledger accessible to all of its authorized participants, which is immutable, time stamped and tamper-proof, making cross-industry supply chains easier to operate. Last week, Australian postal service operator Australia Post announced a partnership with Alibaba to use blockchain technology to improve traceability to combat Australian exports of counterfeit food to China.
(US pharmaceutical companies will use blockchain technology to track prescription drug sources: Baidu Pictures)
Recently, the two companies launched a one-day "track and trace" test in San Francisco. The solution is developed specifically for the pharmaceutical industry or will be a viable way to combat the sale of counterfeit drugs in the US and elsewhere. Participating in the blockchain test activities are not only representatives of pharmaceutical companies, wholesalers and hospitals around the world, but also enterprise-level IT giants and blockchain technology companies. The event marked the first phase of the development of the interoperable blockchain platform for the pharmaceutical industry.
Chronicled co-founder and CEO Samantha Radocchia said in the report:
“In the coming months, we will work closely with leading teams in enterprise blockchain projects to identify the enterprise blockchain that is best suited to provide data entities for the pharmaceutical industry.â€
The blockchain platform will comply with the FDA's Drug Supply Chain Security Act (DSCSA), which was signed by former US President Barack Obama in November 2013. The bill aims to "develop an electronic interoperability system to identify and track certain prescription drugs distributed across the country."
With this in mind, the blockchain solution will support and comply with the DSCSA protocol. In addition, the pilot solution will focus on data privacy while complying with the GS1 standard. GS1 is a global traceability standardization system implemented by all participants in cross-border supply chains around the world.
All in all, this blockchain technology solution aims to develop a cheaper, faster, more efficient and safer standardized method to promote the distribution of prescription drugs.
LinkLab co-founder Susanne Somerville said: "The first phase of the project is to demonstrate that a global pharmaceutical manufacturer can comply with DSCSA regulatory requirements and meet the needs of 2017-2023. In the first phase, we are very happy with a large pharmaceutical manufacturer. cooperating."
There will be other participants in the coming stage, joining all aspects of the typical pharmaceutical supply chain process from manufacturer to pharmacy, hospital, etc.
One of the core products of blockchain technology is a ledger accessible to all of its authorized participants, which is immutable, time stamped and tamper-proof, making cross-industry supply chains easier to operate. Last week, Australian postal service operator Australia Post announced a partnership with Alibaba to use blockchain technology to improve traceability to combat Australian exports of counterfeit food to China.
In the fitness world, there are many definitions of peptide hormones, some of which are suggested to burn fat, build muscle, and improve athletic performance.
Our company provides professional fitness peptides, welcome to inquire
Pt141 Peptides,Lyophilized Powder,Bodybuilding Peptide,Peptides Melanotan 2
XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.xianrhinebiotech.com